February 22, 2017 10:18 AM ESTUpdated February 23, 07:33 AM
News Briefing

PhRMA chief plays fa­vorites in sin­gling out Mar­tin Shkre­li as a ‘bad ac­tor’; Roche ex­tends an­tibi­otics col­lab­o­ra­tion

Shehla Shakoor

Managing Director

→ PhRMA CEO Steve Ubl en­joys hold­ing up Tur­ing’s Mar­tin Shkre­li as an ex­am­ple of the kind of “bad ac­tors” that are giv­ing phar­ma …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

Bris­tol My­ers CEO sig­nals deal­mak­ing will be a top pri­or­i­ty in 2025

Drug­mak­ers see a sub­stan­tial, but man­age­able, hit to busi­ness from tar­iffs. But the worst may lie ahead

Roche CEO warns that tar­iffs could im­pact deal­mak­ing

Roche takes steps to pro­tect it­self from tar­iffs, while Sanofi hangs back

Ther­mo Fish­er buck­les up for US-Chi­na trade war, bud­gets $2B to ease im­pact

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times